Good point. My opinion is that more patients are added in case there are dropouts or someone doesn't return for follow-up. Either way, it's great to know that the trial will be completed by year end.
Quote:
Perhaps the DSMB gave the ok to add them to the 400mg arm.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links